On November 7, 2022, WLF submitted comments to a five-member Independent Expert Panel of the Reagan-Udall Foundation, a nonprofit Congress created to support FDA’s mission. FDA’s Commissioner asked the Foundation to conduct a comprehensive evaluation of its tobacco center. Focusing on three topic areas, WLF’s comments first urged the expert panel to examine the influence tobacco prohibitionists maintain over CTP staff and leadership and how that influence has undermined FDA’s harm-reduction mission. The comment next briefly identified instances where CTP failed to comply with the Constitution and federal statutes when reviewing Electronic Nicotine Delivery System applications. Finally, WLF critiqued FDA’s communication with the public and other stakeholders and demanded that the agency convey facts about non-combustible nicotine products and where they fit into the continuum of risk in a neutral, scientific manner.

Document:

WLF comment